Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Surbhi Jain

Steven Cohen Doubles The S&P 500 — And His Next Bet's All Gut

Wall Street ai6

Steven Cohen's Point72 Asset Management just pulled off what most fund managers only dream of — doubling the S&P 500's three-year return — and he's still not easing up. The billionaire investor's next move? A fresh swing into biotech, backing Palisade Bio Inc (NASDAQ:PALI) — a tiny, high-volatility stock working on gut-health therapies that's suddenly caught Wall Street's attention.

  • Track PALI stock here.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.